2009美国制药行业研究报告【瑞士信贷】..ppt
《2009美国制药行业研究报告【瑞士信贷】..ppt》由会员分享,可在线阅读,更多相关《2009美国制药行业研究报告【瑞士信贷】..ppt(32页珍藏版)》请在三一办公上搜索。
1、06 March 2009Americas/United StatesEquity ResearchMajor Pharmaceuticals/MARKET WEIGHTUS Major Pharmaceuticals,Research AnalystsCatherine J.Arnold212 538 6225catherine.j.arnoldcredit-Michael Faerm212 538 1771michael.faermcredit-Vamil Divan212 538 5394vamil.divancredit-,COMMENTTax Reform Lacks Detail,
2、Worst Case ScenarioMaterially NegativeThe Market is left confused regarding the specific intent of PresidentObamas budget proposal reference to implement internationalenforcement,reform deferral and other tax reform policies.There could be,many important nuances to the plans which are projected to g
3、enerate$210Bnover 10 years.The worst case scenario that we could imagine is a complete elimination ofthe foreign profit tax deferral and a 35%consolidated tax rate for all companies.This would be a material negative for all of our names(Exhibit 1)with 2010earnings decreasing from 6.8%for PFE/WYE pro
4、 forma to 22.2%for SGP.Ofcourse,this negative would hurt many other important sectors in the U.S.Market.The risk is that the revenue projections from reforming tax deferral are large andpopulist politics are against the companies.On the flipside,raising taxes in arecession is controversial and corpo
5、rations could threaten to relocateheadquarters outside the US,which would bode poorly for employment.In Obamas campaign he said it was his desire to broaden the corporate taxbase and eliminate special preferences.He specifically mentioned reforming taxdeferral to end the incentive for companies to s
6、hip jobs overseas.The one-lineris his budget proposal is very vague,implying little detail and possiblysignificant future debate.The projections go from$15Bn to$20Bn to$25Bnand then increase by$1Bn/year.These broad estimates have the appearanceof placeholders,put in to meet the deadline with details
7、 to be determined later.Two possible examples for reforming tax deferral are the recentlyreintroduced bill by Senator Dorgan and the Rangel Bill(expected to bereintroduced this year by the House Ways&Means Chairman).The Dorgan Bill proposes eliminating deferral attributable to products ofUS subsidia
8、ries produced elsewhere and imported into the US.No savingsestimates are available for the Dorgan Bill.Rangels proposal offered$107Bn over 10 years and would delaydeductions allocable to foreign expenses until repatriation of foreign income,thereby encouraging companies to voluntarily forego the def
9、erral.Further insight into Obamas intentions are expected in the coming weeks,or byearly April when a more detailed budget proposal is submitted to Congress.A transcript of a recent conference call we held with Health Policy Expert GeorgeOlsen,where we discussed tax deferral reform and other key asp
10、ects of thePresidents budget proposal,is included in the back of this note.DISCLOSURE APPENDIX CONTAINS IMPORTANT DISCLOSURES,ANALYST CERTIFICATIONS,INFORMATION ONTRADE ALERTS,ANALYST MODEL PORTFOLIOS AND THE STATUS OF NON-U.S ANALYSTS.FOR OTHERIMPORTANT DISCLOSURES,visit www.credit-researchdisclosu
11、res or call+1(877)291-2683.U.S.Disclosure:Credit Suisse does and seeks to do business with companies covered in its research reports.As a result,investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this report.Investorsshould consider this repo
12、rt as only a single factor in making their investment decision.Customers of Credit Suisse in theUnited States can receive independent,third party research on the company or companies covered in this report,at no costto them,where such research is available.Customers can access this independent resea
13、rch at www.credit-orcall 1 877 291 2683 or email equity.researchcredit-to request a copy of this research.,2,06 March 2009Exhibit 1:35%Consolidated Tax Rate Would Lead to 7-22%Negative Impact on 2010 Earnings,CompanyAbbottBristol-MyersEli LillyJohnson and JohnsonMerckPfizerSchering-PloughWyethPFE/WY
14、E Pro Forma,Current CSTax RateEstimate(2009)18.0%24.0%22.0%24.5%23.5%30.0%16.0%30.0%30.0%,Current CS2009 EPSEstimate($)$3.70$1.93$4.15$4.45$3.18$1.83$1.77$3.76$2.14,Adjusted 2009EPS($)*$2.93$1.53$3.47$3.83$2.70$1.70$1.35$3.49$1.99,2009 EPSImpact($)-$0.77-$0.40-$0.68-$0.62-$0.48-$0.13-$0.42-$0.27-$0.
15、15,2009 EPSImpact(%)-20.8%-20.7%-16.4%-13.9%-15.1%-7.1%-23.7%-7.2%-7.0%,Current CSTax RateEstimate(2010)19.0%25.0%22.0%23.5%24.0%30.0%17.0%30.0%30.0%,Current CS2010 EPSEstimate($)$4.21$2.22$4.43$4.95$3.21$2.11$2.07$3.84$2.37,Adjusted 2010EPS($)*$3.35$1.83$3.69$4.19$2.73$1.95$1.61$3.56$2.21,2010 EPSI
16、mpact($)-$0.86-$0.39-$0.74-$0.76-$0.48-$0.16-$0.46-$0.28-$0.16,2010 EPSImpact(%)-20.4%-17.6%-16.7%-15.4%-15.0%-7.6%-22.2%-7.3%-6.8%,Notes:Assumed 35%corporate tax rate for all companies.Source:Company data,Credit Suisse estimatesUS Major Pharmaceuticals,3,06 March 2009Transcript from March 3 Confere
17、nceCall with George Olsen,Operator:Catherine Arnold:,Good morning.My name is Brandy and I will be your conferenceoperator today.At this time Id like to welcome everyone to theCredit Suisse Health Policy conference call with George Olsen.All lines have been placed on mute to prevent any backgroundnoi
18、se.After the speakers remarks there will be a question andanswer session.If you would like to ask a question during thistime,simply press star than the number 1 on your telephonekeypad.If youd like to withdraw your question press the poundkey.Thank you.Ms.Arnold,you may now begin your conference.Tha
19、nks Brandy and good morning everybody.On behalf of the,Credit Suisse Healthcare Team Id like to welcome you to ourconference call.As you know today weve planned to review thehealthcare investment implications of the Presidents budgetproposal and towards that end weve invited Health Policy Expert,Geo
20、rge Olsen.George is the President of Williams&Jensen.Headvises and represents clients throughout the healthcare valuechain.As you may know from past calls,hes been involved withmajor legislative efforts including the role making process ofthese laws.For example,he was involved with Medicare Part D,t
21、he FDA Modernization Act,COBRA,Health Insurance Portabilityand Accountability,and Medicare Catastrophic Coverage,just toname a few.Now George joined us for a call about six weeks to preview theObama health agenda and certainly a lot has transpired sincethat time.Of course,SCHIP passed and we know ha
22、ve a budgetproposal that prioritizes healthcare reform.I think the message from the Obama camp is clear,the change inhealthcare delivery system is seen as an essential part of thisnew administration.In fact,Peter Orszag,Director of the Office ofManagement and Budget was quoted on ABC saying,“TheUS M
23、ajor Pharmaceuticals,4,06 March 2009President is still determined to get health reform passed this yearthat he would propose another revenue source if Congressblocked some of the ideas that are in his current plan.”Certainly theres a lot of details that are not provided in thebudget proposal but wer
24、e asking George today to review whatwas included and what we should expect next.After George isdone the team here will quickly highlight the key takeaways bysector and then wed like to open it up for your questions.With that Ill turn it over George.,George Olsen:,Thank you very much Catherine and I
25、enjoy the opportunity again,to speak to all of you.What Im going to try to do this morning,and its a prettyambitious agenda,sort of like the Presidents budget proposal,but Im going to try to accomplish a couple of tasks.One is to givean overview of the budget process so that we have anunderstanding
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 瑞士信贷 2009 美国 制药 行业 研究 报告 瑞士 信贷
链接地址:https://www.31ppt.com/p-2667504.html